Relationship between Chronic Tension-type Headache, Cranial Hemodynamics, and Cerebrospinal Pressure: Study Involving Provocation with Sumatriptan

Headache

Volumn 44, Issue 2, 2004, Pages 154-159

  Hannerz, Jan ^a   Jogestrand, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cerebrospinal pressure; Chronic tension type headache; Head down tilt provocation; Intracranial pressure; Sumatriptan

Indexed keywords

SUMATRIPTAN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID PRESSURE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEAD TILTING; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; MALE; PAIN ASSESSMENT; PRIORITY JOURNAL; PROVOCATION TEST; SIDE EFFECT; TENSION HEADACHE; VASCULAR RESISTANCE; VENOUS PRESSURE;

ADOLESCENT; ADULT; AGED; CAROTID ARTERY, COMMON; CHRONIC DISEASE; FEMALE; HEAD-DOWN TILT; HUMANS; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; PRESSURE; SEROTONIN AGONISTS; SKULL; SUMATRIPTAN; TENSION-TYPE HEADACHE;

EID: 1242276345     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2004.04032.x     Document Type: Article

References (12)

1. Hannerz J, Jogestrand T. Is chronic tension-type headache a vascular headache? (The relation between chronic tension-type headache and cranial hemodynamics). Headache. 1998;38:668-675.
2. Hannerz J, Schnell PO, Larsson SA, Jacobsson H. Blood pool scintigraphy of the skull in relation to head down tilt provocation of chronic tension-type headache patients and controls. Headache. In press.
3. Humphrey PP, Feniuk W. Mode of action of the anti-migraine drug, sumatriptan. Trends Pharmacol Sci. 1991;12:444-446.
4. Jansen I, Edvinsson L, Mortensen A, Olesen J. Sumatriptan is a potent vasoconstrictor of human dural arteries via 5HT1-like receptor. Cephalalgia. 1991;11:165-168.
5. Parsons A, Whalley ET, Feniuk W, Connor HE, Humphrey PP. 5HT1-like receptors mediate 5-hydroxytryptamine-induced contractions of the human isolated basilar artery. Br J Pharmacol. 1989;96:434-439.
6. Brennum J, Kjeldsen M, Olesen J. The 5-HT1-like sumatriptan has a significant effect in chronic tension-type headache. Cephalalgia. 1992;12:375-379.
7. Brennum J, Brinck T, Schrivert L, et al. Sumatriptan has no clinically relevant effect in treatment of episodic tension-type headache. Eur J Neurol. 1996;3:23-28.
8. Nilsson F, Nilsson T, Edvinsson L, et al. Sumatriptan-induced cerebral vasoconstriction as treatment of experimental intracranial hypertension. Acta Anaesthesiol Scand. 1996;40:612-620.
9. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
10. Lemne C, Jogestrand T, de Faire U. Carotid intimamedia thickness and plaque in borderline hypertension. Stroke. 1995;1:34-39.
11. Nilsson F, Nilsson T, Edvinsson L, Björkman S, Nordström CH. Effects of dihydroergotamine and sumatriptan on human cerebral and peripheral arteries and veins. Acta Anaesthesiol Scand. 1997;41:1257-1262.
12. Hannerz J, Greitz D. Cerebrospinal fluid pressure and venous pressure in "dynamite headache" and cluster headache attacks. Headache. 1992;32:436-438.